Mustang Bio Corp - MBIO Net earnings per share for the trailing year

Public company logo of Mustang Bio Corp (MBIO)

Mustang Bio, Inc. (MBIO) gene therapy development remains independent of market cycles, as demand for oncology treatment is stable. The continuity of research is ensured by duplicating biomaterial supply chains. The annual EPS TTM delta reflects profit dynamics amid alliances with oncology centers and patent acquisitions, with the parameter value equal to 59.00.

mustangbio.com - MBIO Net earnings per share (EPS TTM) (period 02/11/2024 - 11/17/2026)

MBIO (Mustang Bio Corp): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Fundamental valuation:Mustang Bio Inc MBIO
Original product of Mustang Bio Inc

For Mustang Bio, Inc. (MBIO), financial results depend on the success of clinical developments in cancer therapy, which makes the business resilient to market cyclicality. By analyzing this chart of net income per share YoY ttm, an investor assesses the annual EPS growth rate over a rolling period, allowing them to differentiate the actual efficiency of the R&D model from market noise and avoid overpaying for the asset.

Competitor analysis for Mustang Bio, Inc.

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) DSGN (Design Therapeutics, Inc.)|Net earnings per share (EPS TTM) rocketpharma.com RCKT|4DMT - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Net earnings per share (EPS TTM)|proqr.com (PRQR) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CDXS (Codexis Bio)|SGMO - Net earnings per one share for the last twelve months|Nautilus Biotechnology, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Metagenomi, Inc|Precision BioSciences - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Earnings per share for the last twelve months|Exicure Inc. - Earnings per share for the trailing year|IMNN (imunon.com) - Net earnings per share (EPS TTM)|Phio Pharmaceuticals - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX